Decreased use of broad-spectrum antibiotics during COVID-19 epidemic in South Korea
20 April 2021
Early in the COVID-19 pandemic, there was a concern over possible increase in antibiotic use due to co-infections among COVID-19 patients in the community. Here, we evaluate the changes in nationwide use of broad-spectrum antibiotics during the COVID-19 epidemic in South Korea.
Our study found that broad-spectrum antibiotic use was substantially reduced during the COVID-19 epidemic in South Korea. This reduction can be in part due to reduced ARTIs as a result of stringent public health interventions including social distancing measures.
Further reading: The Journal of Infectious Diseases
Author(s): Sukhyun Ryu, Youngsik Hwang, Sheikh Taslim Ali, Dong-Sook Kim, Eili Y Klein, Eric H Y Lau, Benjamin J Cowling
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Every two weeks in your inbox
Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!